Literature DB >> 6435841

Bone loss after glucocorticoid therapy.

V Lo Cascio, E Bonucci, B Imbimbo, P Ballanti, D Tartarotti, G Galvanini, L Fuccella, S Adami.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6435841     DOI: 10.1007/bf02405356

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  16 in total

1.  Fractures in Still's disease.

Authors:  B W BADLEY; B M ANSELL
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

2.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

Authors:  T J Hahn; V C Boisseau; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

3.  The effect of porcine calcitonin on osteoporosis induced by adrenal cortical steroids.

Authors:  J S Thompson; G M Palmieri; L P Eliel; R L Crawford
Journal:  J Bone Joint Surg Am       Date:  1972-10       Impact factor: 5.284

4.  Immobilization and bone.

Authors:  R B Mazess; G D Whedon
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

5.  Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.

Authors:  T J Hahn; L R Halstead; B Strates; B Imbimbo; D T Baran
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

6.  Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids.

Authors:  P D Saville; O Kharmosh
Journal:  Arthritis Rheum       Date:  1967-10

7.  Steroids possessing nitrogen atoms. 3. Synthesis of new highly active corticoids. [17-alpha, 16-alpha-d]oxazolino steroids.

Authors:  G Nathanson; G Winters; E Testa
Journal:  J Med Chem       Date:  1967-09       Impact factor: 7.446

8.  Bone histomorphometric reproducibility in normal patients.

Authors:  M C de Vernejoul; D Kuntz; L Miravet; D Goutallier; A Ryckewaert
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

Review 9.  Osteoporosis in rheumatoid arthritis and corticosteroid induced osteoporosis.

Authors:  H Duncan
Journal:  Orthop Clin North Am       Date:  1972-11       Impact factor: 2.472

10.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Authors:  D M Reid; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
View more
  18 in total

Review 1.  Is there an effective treatment for glucocorticoid-induced osteoporosis?

Authors:  D T Villareal; R Civitelli; C Gennari; L V Avioli
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 2.  Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

Authors:  Maurizio Rossini; Giovanni Orsolini; Ombretta Viapiana; Silvano Adami; Davide Gatti
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

3.  Sequential study of bone mineral density in patients with systemic lupus erythematosus.

Authors:  F Formiga; J M Nolla; I Moga; D Roig-Escofet
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

Review 4.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

5.  Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.

Authors:  G Aicardi; S Milani; B Imbimbo; M Vignolo; E Di Battista; R Gusmano; A Terragna; G Cordone; F Cottafava; R Coppo
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

6.  Effects of prednisone and deflazacort on vertebral bone mass.

Authors:  C Gennari; B Imbimbo
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

Review 7.  Minimization of steroids in kidney transplantation.

Authors:  Arthur J Matas
Journal:  Transpl Int       Date:  2008-07-24       Impact factor: 3.782

Review 8.  Prevention and treatment of postmenopausal osteoporosis.

Authors:  R B Hallworth
Journal:  Pharm World Sci       Date:  1998-10

9.  Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.

Authors:  L Li; A Chang; M Naesens; N Kambham; J Waskerwitz; J Martin; C Wong; S Alexander; P Grimm; W Concepcion; O Salvatierra; M M Sarwal
Journal:  Am J Transplant       Date:  2009-05-13       Impact factor: 8.086

Review 10.  Deflazacort. A review of its pharmacological properties and therapeutic efficacy.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.